Clinical Trial Update: A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

View source ↗

Summary

Completed study evaluating real-world usage and effectiveness of Elocta and Alprolix in patients with Haemophilia A or B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Alprolix (eftrenonacog alfa)
• Elocta (efmoroctocog alfa)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Haemophilia A, Haemophilia B | Status: COMPLETED